Our objective is to invest in companies
in the lower and middle markets that
have developed new technologies
products and services which when
grown organically and merged with
complimentary business entities can
be grown rapidly to increase global
market share and financially realise
the potential of the combined entities

Investment Focus

silhouette of mountain goat on cliff

The 393 Private Equity Team identify, invest in and grow entities that have developed new, or enhanced existing technology, products and services and have reached a point where they need a hands on business partner to invest in their business.

393 will invest in companies financially and organisationally so the leadership team can focus on sales, marketing, recruitment brand and technology to ensure rapid future growth is achieved through acquisitions and organically, in the following markets:

Manufacturing
- Defence Manufacturing and Supplies
- Pharmaceutical & Chemical Processing
- Medical Device Manufacturing
- Life Sciences Biotechnology Devices

SaaS, Supply Chain and Platforms
- Defence, Pharmaceutical and Medical
- Artificial Intelligence
- Integrated Risk, Compliance, Certification Software

Life Essentials (Food, Water, Health, Shelter)
- Food Supply Chain
- Water Treatment Technology
- Human Drug Development
- Antimicrobial Resistance (MRSA, VRE, MDR-TB)
- Real Estate

AGRISCIENTIFIC specialises in Agribusiness, categories include: Agriculture, Livestock, Fisheries, Food Processing & Distribution,
Forestry, Biofuel and Biotechnology.

At the current rate of global population growth and the predicted increase in crop destruction due to environment stress from global warming and pathogens, every country in the World however rich or poor, will be impacted by food shortages rationing and starvation by 2050

GENETIC ENGINEERING TECHNOLOGY (SEEDS, TUBERS)
we will invest in companies who use genetic engineering to develop genetically edited seeds, tubers and grain to solve
the crop destruction challenges farmers face with drought, floods and salinity

GENETIC ENGINEERING TECHNOLOGY (LIVESTOCK)
we will invest in companies who specialise in animal genetics

AQUACULTURE we will invest in Aquaculture also known as Aquafarming which is the farming of aquatic plants, algae, fish, crustaceans, mollusks and other organisms involving cultivating freshwater & saltwater populations under controlled conditions. We are currently investigating processes for bioengineering the accelerated growth rate of enriched nutritional content seaweed, so it can be used as low cost, high nutrition, mineral rich livestock feed.

Transaction Types

We invest across three types of scenarios that are consistent with our investment criteria

Skyline of Lima, Peru featuring modern skyscrapers, highways, and green spaces.

Divestitures / Carve-Out’s

The acquisition of highly integrated business divisions on complex global shared services manufacturing ERP platforms like SAP, that are very challenging and difficult to carve out and and transition to being fully operationally stand alone self supporting legal entities quickly. And the acquisition of standalone entities considered non core by its corporate or private equity parent.

Scientist analyzing plant samples with a tablet in a laboratory, featuring a microscope, test tubes, and digital graphics of molecular structures.

Venture Capital Investment / Growth Capital

We will invest in companies that need financial capital to grow their businesses by developing and taking new products to market. We are currently working with pioneering leaders in scientific research who will use our investment strategies to provide them with the financial and commercial support they need to deliver their world changing products globally.

Person writing mathematical equations on a chalkboard

Distressed Investing / Turnarounds

Investing in or acquiring companies that are underperforming or in short term financial distress, to stabilise them financially and operationally and once profitable merging selling them or merging them with similar companies in our portfolio who are in the same market space or industry.

Team

393 has a European based team complemented by a global network of senior advisors, industry subject matter experts and business development (rapid EBITDA) growth professionals, who have worked together previously and managed over $10billion of acquisitions and divestiture deals.

Brian Buttery

Managing Partner
Fundraising / Investing / Legal

Smiling man in a suit holding a baby indoors.

Brian N Buttery

Investment Director
Defence / Transportation

Stylized fox head above the number 393 on a white background.

Strategy & Analysis

Outsource Partner
Strategic Acquisitions & Mergers

Illustration of a fox face with the number 393 beneath it.

Interim CFO

Director
Fund Management / Compliance

Stylized fox face above the number 393 in bold black font.

Commercial

Outsource Partner
Sales / Marketing / Brand / Comms

Person with red hair wearing heart-shaped sunglasses and a white shirt, standing in a garden with pink flowers and green plants.

Paula Vale

Partner
Investing / Real Estate / Hospitality

Portrait of a woman with blonde hair and a black shirt, wearing a necklace with a pendant, against a gray background.

Bliss Buttery

Investment Director
Life Sciences / Agriscience / Bioscience

Black and white photo of a man in front of a whiteboard with diagrams.

Dr Jochen Davis

Investment Director
Manufacturing / Digital Technology

Man in suit with patterned tie standing outside a building with brick wall in the background.